by Pomegranite | Dec 1, 2025
Whether they are born with HIV or contract the virus later, all young people living with HIV need to take medication to control the virus and stay healthy. If they are diagnosed before their immune system has been too damaged and take the treatment they are...
by Pomegranite | Feb 5, 2024
The resource, titled “”Paediatric Abacavir/Lamivudine/Dolutegravir (pALD) Fixed-Dose Combination: Introduction and Rollout Planning Considerations for National Programmes,”” focuses on the transition in HIV treatment for children. With the...
by Pomegranite | Dec 12, 2018
Gender disparities are striking with approximately 170,000 new HIV infections among AGYW in 2017, more than double the estimated 75,000 among adolescent boys and young men. Regional update: The adolescence HIV landscape
by Pomegranite | Nov 29, 2016
Despite significant progress made in HIV treatment and prevention, with various global targets speaking to the end of AIDS, current evidence suggests that this optimism does not hold for young people1. AIDS-related deaths among adolescents in sub-Saharan Africa have...
